|
|
40
|
0131DH
|
KLARICID 50MG/ML SUSP (ABB/PHA) CLARITHROMYCI
|
CLARITHROMYCIN
|
KLARICID
|
60ML
|
C
|
15.79
|
0.26
|
SUSPENSION
|
0
|
ML
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0131DH
|
KLARICID 50MG/ML SUSP (ABB/PHA) CLARITHROMYCI (C)
|
CLARITHROMYCIN
|
KLARICID
|
60ML
|
C
|
15.79
|
0.2632
|
SUSPENSION
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
8121292
|
OTHER MACROLIDES
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
OTHER MACROLIDES
|
2023-03-02
|
|
|
40
|
0131DJ
|
KLARICID 25MG/ML SUSP (ABB/PHA) CLARITHROMYCI
|
CLARITHROMYCIN
|
KLARICID
|
60ML
|
C
|
11.50
|
0.19
|
SUSPENSION
|
0
|
ML
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0131DJ
|
KLARICID 25MG/ML SUSP (ABB/PHA) CLARITHROMYCI (C)
|
CLARITHROMYCIN
|
KLARICID
|
60ML
|
C
|
11.5
|
0.1917
|
SUSPENSION
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
8121292
|
OTHER MACROLIDES
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
OTHER MACROLIDES
|
2023-03-02
|
|
|
41
|
0131DU
|
KLARICID 50MG/ML SUSP (ABB/SBI) CLARITHROMYCIN
|
CLARITHROMYCIN
|
KLARICID
|
60ML
|
C
|
19
|
0.3167
|
SUSP
|
60
|
ML
|
ABB
|
ABBOTT
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
08121292
|
OTHER MACROLIDES
|
|
|
|
ORAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
41
|
0131DV
|
KLARICID 25MG/ML SUSP (ABB/SBI) CLARITHROMYCIN
|
CLARITHROMYCIN
|
KLARICID
|
60ML
|
C
|
14.22
|
0.2369
|
SUSP
|
100
|
ML
|
ABB
|
ABBOTT
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
08121292
|
OTHER MACROLIDES
|
|
|
|
ORAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0141FU
|
KLARICID XL 500MG TAB (ABB/PHA) CLARITHROMYCI
|
CLARITHROMYCIN
|
KLARICID XL
|
10'S
|
C
|
16.66
|
1.67
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0141FU
|
KLARICID XL 500MG TAB (ABB/PHA) CLARITHROMYCI (C)
|
CLARITHROMYCIN
|
KLARICID XL
|
10'S
|
C
|
16.66
|
1.666
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
8121292
|
OTHER MACROLIDES
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
OTHER MACROLIDES
|
2023-03-02
|
|
|
40
|
0141FV
|
KLARICID 500MG TAB (ABB/PHA) CLARITHROMYCIN
|
CLARITHROMYCIN
|
KLARICID
|
10'S
|
C
|
16.72
|
1.67
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
Price Change
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-05-05
|
|
|
41
|
0141HG
|
KLARICID 500MG TAB (ABB/SBI) CLARITHROMYCIN
|
CLARITHROMYCIN
|
KLARICID
|
10'S
|
C
|
11.96
|
1.1961
|
TAB
|
14
|
TAB
|
ABB
|
ABBOTT
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
08121292
|
OTHER MACROLIDES
|
|
|
|
ORAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
41
|
0141HH
|
KLARICID XL 500MG ER TAB (ABB/SBI) CLARITHROMYCIN
|
CLARITHROMYCIN
|
KLARICID XL
|
10'S
|
C
|
17.34
|
1.7343
|
|
0
|
TABE
|
ABB
|
ABBOTT
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
08121292
|
OTHER MACROLIDES
|
|
|
|
ORAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0211Y
|
MEROPENEM 500MG INJ (ABB/PHA)
|
MEROPENEM
|
MEROPENEM
|
500MG VIAL
|
BQ
|
11.50
|
11.50
|
INJECTION
|
0
|
VIAL
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0211Y
|
MEROPENEM 500MG INJ (ABB/PHA) (BQ)
|
MEROPENEM
|
MEROPENEM
|
500MG VIAL
|
BQ
|
11.5
|
11.5
|
INJECTION
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
8120708
|
CARBAPENEMS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
IV
|
6
|
CARBAPENEMS
|
2023-03-02
|
|
|
41
|
1261L
|
ULTANE (4456-02) (ABB/PHA) SEVOFLURANE
|
SEVOFLURANE
|
ULTANE (4456-02)
|
250ML
|
BQ
|
264.74
|
264.7376
|
SOLN
|
30
|
BOTT
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280416
|
INHALATION ANAESTHETICS
|
|
|
|
INHALATION
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
40
|
1261L
|
ULTANE (4456-02) (ABB/PHA) SEVOFLURANE
|
SEVOFLURANE
|
ULTANE (4456-02)
|
250ML
|
BQ
|
265.04
|
265.04
|
SOLUTION
|
0
|
BOTT
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280416
|
INHALATION ANAESTHETICS
|
2022-04-01
|
2024-03-31
|
|
INHALATION
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
40
|
2962R
|
POST DAY 1.5MG TAB (ABB/PHA) LEVONORGESTREL
|
LEVONORGESTREL
|
POST DAY
|
1'S
|
C
|
9.89
|
9.89
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6812
|
CONTRACEPTIVES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
40
|
2962R
|
POST DAY 1.5MG TAB (ABB/PHA) LEVONORGESTREL (C)
|
LEVONORGESTREL
|
POST DAY
|
1'S
|
C
|
9.89
|
9.89
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6832
|
PROGESTINS
|
2022-04-01
|
2023-04-13
|
Delete from contract
|
Oral
|
0
|
PROGESTINS
|
2023-03-02
|
|
|
40
|
2991Q
|
SYNTHROID 0.1MG TAB (ABB/PHA) THYROXINE
|
THYROXINE
|
SYNTHROID
|
30'S
|
C
|
7.75
|
0.26
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
683604
|
THYROID AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
40
|
2991Q
|
SYNTHROID 0.1MG TAB (ABB/PHA) THYROXINE (C)
|
THYROXINE
|
SYNTHROID
|
30'S
|
C
|
7.75
|
0.2583
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
683604
|
THYROID AGENTS
|
2022-04-01
|
2002-03-31
|
Delete from contract
|
Oral
|
0
|
THYROID AGENTS
|
2023-03-02
|
|
|
41
|
2991T
|
SYNTHROID 0.1MG TAB (ABB/SBI) THYROXINE
|
THYROXINE
|
SYNTHROID
|
30'S
|
C
|
8.07
|
0.2691
|
TAB
|
60
|
TAB
|
ABB
|
ABBOTT
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
6836
|
THYROID AGENTS
|
|
|
|
ORAL
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|